logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • China News Weekly 83 – Fosun Acquires China Rights to HCC Diagnostic with $10 Million Glycotest Investment

China News Weekly 83 – Fosun Acquires China Rights to HCC Diagnostic with $10 Million Glycotest Investment

NAI China News Weekly - www.nai500.com
Published on: Oct 24, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

 

Click here to find more details

This is NAI’s new China News Weekly. We will be covering the latest Chinese foreign investment trends every week. To continue to receive our China News Weekly, please click Here to subscribe

China News Financial Service Fintech Life Science Technology

Related Posts

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns

AlphaFold是什么?如何投资AlphaFold?

Tenet Healthcare Beats Q2 Expectations, Raises Full-Year Guidance, Sending Stock Up Over 17%

U.S. Launches ‘Prometheus’ AI Nuclear Initiative, With X-Energy, Oklo Among Partners

Verizon Communications Sees Strong Subscriber Growth in Q2, Over $1 Billion Dark Fiber Deal Opens New AI Revenue Horizons

可口可乐:估值回调下的“股息王”机遇

Coca-Cola Has Raised Its Dividend for 64 Consecutive Years, and Investors Are Positioning Ahead of the Earnings Release

中美三大出行平台携手,在伦敦启动无人驾驶出租车路测

Moody’s Warns of AI Investment Boom as Trillion-Dollar Spending Tests Returns

Weekly Market Recap (July 25) - The U.S. ‘Tungsten Ban’ and Nevada’s Strategic Opportunity

Weekly Market Recap (July 25) – The U.S. ‘Tungsten Ban’ and Nevada’s Strategic Opportunity

Related News

Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns

1 day ago.

Tenet Healthcare Beats Q2 Expectations, Raises Full-Year Guidance, Sending Stock Up Over 17%

1 day ago.

Verizon Communications Sees Strong Subscriber Growth in Q2, Over $1 Billion Dark Fiber Deal Opens New AI Revenue Horizons

1 day ago.

Moody’s Warns of AI Investment Boom as Trillion-Dollar Spending Tests Returns

1 day ago.

Top Stories

Oracle Stock Has Crashed, But Analysts Say It Could Still Double
Technology

Oracle Stock Has Crashed, But Analysts Say It Could Still Double

Technology

The New Frontier: Where Will the Next Wave of Wealth Emerge?

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada